Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

AXIOM IMPLANT ?2.8 x 10.0: medical device reports filed with FDA

357 reports name it, 2021–2026. Manufacturer given most often on reports: Anthogyr. Product code DZE.

357
device reports naming the brand
0% of all MAUDE reports · about 70 a year
97
reports, 12 months to August 2026
85 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 357 reports that name the brand "AXIOM IMPLANT ?2.8 x 10.0" (endosseous dental implant), received between June 2021 and August 2026; the manufacturer given most often on reports is Anthogyr. Spellings of one product vary from report to report.

97 reports arrived in the 12 months to August 2026, up 14% from 85 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (90.2%), loss of osseointegration (9%) and fracture (1.7%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01223Sep 2021: 0Oct 2021: 0Nov 2021: 4Dec 2021: 02022Jan 2022: 13Feb 2022: 5Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 6Jul 2022: 2Aug 2022: 1Sep 2022: 0Oct 2022: 3Nov 2022: 3Dec 2022: 42023Jan 2023: 0Feb 2023: 2Mar 2023: 0Apr 2023: 1May 2023: 6Jun 2023: 9Jul 2023: 11Aug 2023: 7Sep 2023: 7Oct 2023: 3Nov 2023: 14Dec 2023: 112024Jan 2024: 5Feb 2024: 8Mar 2024: 6Apr 2024: 3May 2024: 10Jun 2024: 4Jul 2024: 2Aug 2024: 4Sep 2024: 9Oct 2024: 6Nov 2024: 4Dec 2024: 82025Jan 2025: 5Feb 2025: 4Mar 2025: 9Apr 2025: 2May 2025: 0Jun 2025: 23Jul 2025: 8Aug 2025: 7Sep 2025: 16Oct 2025: 3Nov 2025: 18Dec 2025: 102026Jan 2026: 8Feb 2026: 4Mar 2026: 10Apr 2026: 10May 2026: 2Jun 2026: 9Jul 2026: 6Aug 2026: 1

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0531052021: 2520212022: 3720222023: 7120232024: 6920242025: 10520252026: 502026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%357
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%357
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate32290.2%62.8%
Loss of osseointegration329%22.4%
Fracturea broken bone61.7%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis4913.7%
Painpain, site not specified298.1%
Inflammationinflammation246.7%
Swelling/ edema133.6%
Hemorrhage/blood loss/bleeding30.8%
Numbnessnumbness30.8%
Fistula10.3%
Hypersensitivity/allergic reaction10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAXIOM IMPLANT ?2.8 x 10.0Product code DZEAll MAUDE reports
Reports3573,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about AXIOM IMPLANT ?2.8 x 10.0 reports

How many FDA reports name AXIOM IMPLANT ?2.8 x 10.0?

357 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 97 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (90.2%), loss of osseointegration (9%) and fracture (1.7%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that AXIOM IMPLANT ?2.8 x 10.0 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.